eNews - March 2008 CellGenix Technologie Transfer GmbH Am Flughafen 16 79108 Freiburg (Germany)

CellGro^® Research-grade Cytokines

CellGenix, the world leading manufacturer of cytokines for Clinical Cell Therapy Applications, announces the launch of its two newest research-grade products:

E.coli-derived hum. rec. TPO and Flt-3L

Your advantages:

Robust processes

• Excellent yield
• Excellent activity

Safety improvement

• No virus contamination issues
• Easy regulatory compliance

GMP-upgrade already under way

• Suitable for all clinical trial phases

Get your free test sample today!

CellGro^® Research-grade Cytokines:

• Dendritic Cell generation (IL-4, GM-CSF, TNF-alpha, IL-1beta, IL-6)
• Hematopoietic stem and progenitor cell expansion (SCF, TPO, Flt3-L, IL-3)
• Mesenchymal stem cell expansion & chondrocyte cultivation (bFGF)

Interested?

Please give our Customer Service a call: +49 (0)761 / 88889-330
or send an email to: info@cellgenix.com.

CellGro^® is a registered trade mark in several European countries and Japan.
In the U.S.A. and Canada CellGro^® products are distributed under the name of CellGenix™.

Download or print this eNews as PDF